388 related articles for article (PubMed ID: 20513524)
21. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
[TBL] [Abstract][Full Text] [Related]
22. Churg-Strauss syndrome: survival for 26 years.
Vemuri P; Greenberger PA; Patterson R
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):640-3. PubMed ID: 12086374
[TBL] [Abstract][Full Text] [Related]
23. Eosinophilic pneumonias.
Cottin V; Cordier JF
Allergy; 2005 Jul; 60(7):841-57. PubMed ID: 15932372
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the diagnosis of Churg-Strauss syndrome.
Churg A
Mod Pathol; 2001 Dec; 14(12):1284-93. PubMed ID: 11743052
[TBL] [Abstract][Full Text] [Related]
25. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
27. Churg-strauss syndrome in patients treated with omalizumab.
Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
[TBL] [Abstract][Full Text] [Related]
28. Current update on eosinophilic lung diseases and anti-IL-5 treatment.
Samitas K; Rådinger M; Bossios A
Recent Pat Antiinfect Drug Discov; 2011 Sep; 6(3):189-205. PubMed ID: 21824072
[TBL] [Abstract][Full Text] [Related]
29. Churg-Strauss syndrome: update on pathophysiology and treatment.
Vaglio A; Moosig F; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):24-30. PubMed ID: 22089097
[TBL] [Abstract][Full Text] [Related]
30. Ear, nose and throat manifestations of Churg-Strauss syndrome.
Bacciu A; Bacciu S; Mercante G; Ingegnoli F; Grasselli C; Vaglio A; Pasanisi E; Vincenti V; Garini G; Ronda N; Ferri T; Corradi D; Buzio C
Acta Otolaryngol; 2006 May; 126(5):503-9. PubMed ID: 16698700
[TBL] [Abstract][Full Text] [Related]
31. [Genital papules revealing a Churg-Strauss syndrome].
Rivollier C; Martin L; Machet L; Machet MC; Lorette G
Ann Dermatol Venereol; 2002; 129(8-9):1049-52. PubMed ID: 12442106
[TBL] [Abstract][Full Text] [Related]
32. [Churg-Strauss syndrome. Personal caseload and review of the literature].
Manganelli P; Troise Rioda W; Buzio C; Pavesi G; Gemignani F
Minerva Med; 1994; 85(7-8):387-93. PubMed ID: 7936357
[TBL] [Abstract][Full Text] [Related]
33. A case of Churg-Strauss syndrome with refractory otitis media.
Saka N; Seo T; Shimano K; Kashiba K; Mori T; Sakagami M
Auris Nasus Larynx; 2009 Feb; 36(1):79-81. PubMed ID: 18384991
[TBL] [Abstract][Full Text] [Related]
34. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.
Busse WW; Katial R; Gossage D; Sari S; Wang B; Kolbeck R; Coyle AJ; Koike M; Spitalny GL; Kiener PA; Geba GP; Molfino NA
J Allergy Clin Immunol; 2010 Jun; 125(6):1237-1244.e2. PubMed ID: 20513521
[TBL] [Abstract][Full Text] [Related]
35. Churg-Strauss syndrome: a diagnosis not to be forgotten.
Zanaboni D; Maccabruni A; Bonacci E; Caprioli M; Caporali R; Mariani B
New Microbiol; 2008 Apr; 31(2):285-90. PubMed ID: 18623996
[TBL] [Abstract][Full Text] [Related]
36. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
Oldhoff JM; Darsow U; Werfel T; Katzer K; Wulf A; Laifaoui J; Hijnen DJ; Plötz S; Knol EF; Kapp A; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
[TBL] [Abstract][Full Text] [Related]
37. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.
Taniguchi M; Tsurikisawa N; Higashi N; Saito H; Mita H; Mori A; Sakakibara H; Akiyama K
Allergol Int; 2007 Jun; 56(2):97-103. PubMed ID: 17460439
[TBL] [Abstract][Full Text] [Related]
38. Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome.
Rolla G; Tartaglia N; Motta M; Ferrero N; Bergia R; Guida G; Heffler E
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):595-7. PubMed ID: 17601277
[TBL] [Abstract][Full Text] [Related]
39. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
[TBL] [Abstract][Full Text] [Related]
40. The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
Int Arch Allergy Immunol; 2011; 155 Suppl 1():46-52. PubMed ID: 21646795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
